WVE-007 for obesity

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 31 Jan 2025: Trial started, NCT06842186
  2. 24 Feb 2025: Trial registered, NCT06842186

The trials

NCT06842186: A Phase 1/2a Study of WVE-007 in Adults Living With Overweight or Obesity

State
Under way
Phase
Phase 1 and Phase 2
People
400 planned
Started
31 Jan 2025
Primary completion
Dec 2027
Arms
Cohort 1, Cohort 2, Cohort 3, Cohort 4, Cohort 5, Cohort 6, Cohort 7
Results
None posted
  1. 31 Jan 2025: Trial started
  2. 24 Feb 2025: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.